Vivos (RDGL) Enterprise Value Growth (3y) (2013 - 2025)
Vivos (RDGL) Enterprise Value Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.97% |
| Sep 30, 2025 | -3.47% |
| Jun 30, 2025 | -36.30% |
| Mar 31, 2025 | -38.77% |
| Dec 31, 2024 | -11.27% |
| Sep 30, 2024 | 15.04% |
| Jun 30, 2024 | 7.30% |
| Mar 31, 2024 | 18.28% |
| Dec 31, 2023 | -20.78% |
| Sep 30, 2023 | -368.62% |
| Jun 30, 2023 | -91.54% |
| Dec 31, 2022 | -337.44% |
| Sep 30, 2022 | -132.31% |
| Jun 30, 2022 | -398.10% |
| Mar 31, 2022 | -208.07% |
| Dec 31, 2021 | -563.69% |
| Mar 31, 2021 | -5,294.58% |
| Dec 31, 2020 | -377.18% |
| Sep 30, 2020 | 12.26% |
| Jun 30, 2020 | 12.34% |